Supporting data for "Cell cycle inhibitors for liver cancer treatment"

figure

posted on 2022-09-09, 03:19 authored by Po Yee Wong

A. Data showing the gene expression level of tubulin (TUBB), aurora kinase B (AURKB), CDK4 and CDK6 in HCC tissue and corresponding non-tumorous liver tissues (NT) in HCC patients. Scatter dot plot: mean with SD. Student’s t test: * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.

B. Data showing the correlation between HCC patients with normal or high expression level of TUBB, AURKB, CDK4 and DDX41 and the percentage of survival in overall survival l model. Log-rank (Mantel-Cox) test: * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.

C. Data showing the correlation between HCC patients with normal or high expression level of TUBB, AURKB and CDK4 and the percentage of survival in disease-free survival model. Log-rank (Mantel-Cox) test: * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.

D. Data showing the aneuploidy score, Buffer hypoxia score and Winter hypoxia score of HCC patients with normal or high expression level of DDX41. Wilcoxon test: * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.